A critical review on marine serine protease and its inhibitors: A new wave of drugs?

Int J Biol Macromol. 2021 Feb 15:170:674-687. doi: 10.1016/j.ijbiomac.2020.12.134. Epub 2020 Dec 30.

Abstract

Marine organisms are rich sources of enzymes and their inhibitors having enormous therapeutic potential. Among different proteolytic enzymes, serine proteases, which can be obtained from various marine organisms show a potential to biomedical application as thrombolytic agents. Although this type of proteases plays a crucial role in almost all biological processes, their uncontrolled activity often leads to several diseases. Accordingly, the actions of these types of proteases are regulated by serine protease inhibitors (SPIs). Marine SPIs control complement activation and various other physiological functions, such as inflammation, immune function, fibrinolysis, blood clotting, and cancer metastasis. This review highlights the potential use of serine proteases and their inhibitors as the new wave of promising drugs.

Keywords: Marine organisms; Pharmaceutical potential; Serine protease; Serine protease inhibitor.

Publication types

  • Review

MeSH terms

  • Animals
  • Aquatic Organisms / metabolism*
  • Blood Coagulation / drug effects
  • Fibrinolysis / drug effects
  • Humans
  • Inflammation / drug therapy
  • Inflammation / metabolism
  • Serine Proteases / metabolism*
  • Serine Proteinase Inhibitors / pharmacology*

Substances

  • Serine Proteinase Inhibitors
  • Serine Proteases